Appendix 3Y
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
| Introduced 30/9/2001. | Amended 01/01/11 |
| Name of Entity: | Radiopharm Theranostics Limited (ASX: RAD) |
| ABN: | 57 647 877 889 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director: | Riccardo Canevari |
| Date of Last Notice: | 22 September 2026 |
Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or Indirect Interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
N/A |
| Date of change | 30 September 2026 |
| No. of securities held prior to change | Shares | Options |
| Direct | 23,918,875 | 187,301,188 |
| Indirect | 2,650,000 | - |
| Total | 26,568,875 | 187,301,188 |
| Class | Unlisted Options |
| Number acquired | Nil |
| Number disposed | 24,000,000 Unlisted Options, EXP 30 Sept 2026, EX $0.06 |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Nil |
| + See chapter 19 for defined terms. | |
| 01/01/2011 | Appendix 3Y Page 1 |
Appendix 3Y
Change of Director’s Interest Notice
| No. of securities held after change | Shares | Options |
| Direct | 23,918,875 | 163,301,188 |
| Indirect | 2,650,000 | - |
| Total | 26,568,875 | 163,301,188 |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Expiry of Unlisted Options |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| Interest after change | N/A |
| + See chapter 19 for defined terms. | |
| Appendix 3Y Page 2 | 01/01/2011 |
Appendix 3Y
Change of Director’s Interest Notice
Part 3 – Closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? |
N/A |
| + See chapter 19 for defined terms. | |
| 01/01/2011 | Appendix 3Y Page 3 |